The Role of Cognitive Reserve in the clinical presentation of Alzheimer s Disease Dorene M. Rentz, PsyD

Similar documents
Cognitive Aging: Defining normal vs. disease?

The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment

Supplementary Material. Functional connectivity in multiple cortical networks is associated with performance. across cognitive domains in older adults

Imaging of Alzheimer s Disease: State of the Art

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre

Mild Cognitive Impairment (MCI)

Understanding Symptoms, Causes, and Risks for Alzheimer s Disease

MASSACHUSETTS ALZHEIMER S DISEASE RESEARCH CENTER

Dementia, Cognitive Aging Services and Support

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer s disease

Regulatory Challenges across Dementia Subtypes European View

review of existing studies on ASL in dementia Marion Smits, MD PhD

Dementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada

Round table: Moderator; Fereshteh Sedaghat, MD, PhD Brain Mapping in Dementias and Non-invasive Neurostimulation

Carol Manning, PhD, ABPP-CN Director, Memory Disorders Clinic University of Virginia

Update on functional brain imaging in Movement Disorders

New life Collage of nursing Karachi

Brain imaging for the diagnosis of people with suspected dementia

Introduction, use of imaging and current guidelines. John O Brien Professor of Old Age Psychiatry University of Cambridge

Neuro degenerative PET image from FDG, amyloid to Tau

Tammie Benzinger, MD, PhD

The added value of the IWG-2 diagnostic criteria for Alzheimer s disease

NIH Public Access Author Manuscript Dement Geriatr Cogn Disord. Author manuscript; available in PMC 2013 August 28.

Neuropsychiatric symptoms as predictors of MCI and dementia: Epidemiologic evidence

Synaptic changes in dementia: links to cognition and behaviour

Dementia is not normal aging!

4/28/2017. Aging with Down Syndrome. Second Annual USC UCEDD Community Education Conference May 19, 2017

USE OF BIOMARKERS TO DISTINGUISH SUBTYPES OF DEMENTIA. SGEC Webinar Handouts 1/18/2013

Developing More Effective Paradigms for Assessing and Monitoring Cognitive Change Across the MCI and PreMCI Spectrum

Early Diagnosis of Alzheimer s Disease and MCI via Imaging and Pattern Analysis Methods. Christos Davatzikos, Ph.D.

Diagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16

P20.2. Characteristics of different types of dementia and challenges for the clinician

AT RISK, SCI, EMCI: THE ALPHABET SOUP OF PRECLINICAL AND PRODROMAL ALZHEIMER DISEASE

Biomarkers Workshop In Clinical Trials Imaging for Schizophrenia Trials

The Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing

How can the new diagnostic criteria improve patient selection for DM therapy trials

Changing diagnostic criteria for AD - Impact on Clinical trials

Anosognosia, or loss of insight into one s cognitive

MENTAL DISORDERS. Mental Health VS Psychiatry. Mental Health VS Psychiatry. Community Mental Health in Elderly and Geriatric Psychiatry.

Alzheimer s disease dementia: a neuropsychological approach

Secondary prevention of Alzheimer s dementia: neuroimaging contributions

Visual Dysfunction in Alzheimer s Disease and Parkinson s Disease

Dementia: A Comprehensive Update Neuroimaging, CSF, and genetic biomarkers in dementia

Depression: An Important Risk Factor for Cognitive Decline

Moving Targets: An Update on Diagnosing Dementia in the Clinic

Clinical Applications of fmri

Parkinson e decadimento cognitivo. Stelvio Sestini

MILD HYPERTHYROIDISM CAUSES A PSEUDO-ALZHEIMER S PATTERN OF CEREBRAL METABOLISM WHICH IS REVERSIBLE WITH CEREBRAL PERFUSION STIMULANTS

BINGES, BLUNTS AND BRAIN DEVELOPMENT

دمانس های اتوایمون دکتر رضائی طلب نورولوژیست آذر 95

Intelligence quotient adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Supplementary Online Content

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

Addressing Barriers to Early Detection for Alzheimer's Disease

Diagnosis of Alzheimer s Disease with [18F]PET in Mild and Asymptomatic Stages

An integrated natural disease progression model of nine cognitive and biomarker endpoints in patients with Alzheimer s Disease

The Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing an example of Australian research on Alzheimer s disease

Washington University: Setting the Stage for Secondary Prevention Trials in Alzheimer Disease

NIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14.

Erin Cullnan Research Assistant, University of Illinois at Chicago

NEWSLETTER AIBL STUDY

Probable Early-onset Alzheimer s Disease Diagnosed by Comprehensive Evaluation and Neuroimage Studies

Alzheimer s Disease Update: From Treatment to Prevention

Stephen Salloway, M.D., M.S. Disclosure of Interest

Engineering team: Andrew Lang, Bo Liu, Jerry Prince, Brian Caffo, Murat bilgel, Runze Tan, Chun-Guang, and Zhou Ye; Medical team: Kostas Lyketsos,

MALATTIA CARDIOVASCOLARE NELL ANZIANO DIABETICO. Diabete e demenza. Enzo Manzato

ASL Perfusion Imaging: Concepts and Applications

SUPPLEMENTARY INFORMATION In format provided by Frank et al. (JULY 2010)

#CHAIR2015. Miami, Florida. September 24 26, JW Marriott Miami. Sponsored by

Brain Imaging studies in substance abuse. Jody Tanabe, MD University of Colorado Denver

Diffusion Tensor Imaging in Dementia. Howard Rosen UCSF Department of Neurology Memory and Aging Center

Caring Sheet #11: Alzheimer s Disease:

T he ability to consciously learn and retain new information

212 Index C-SB-13,

The ABCs of Dementia Diagnosis

Supplemental Information. Triangulating the Neural, Psychological, and Economic Bases of Guilt Aversion

Functional neural correlates of anosognosia in Alzheimer s disease. University Medical Center Groningen

The current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

I do not have any disclosures

Alzheimer s Disease. Clinical characteristics of late-onset Alzheimer s disease (LOAD) A/Prof David Darby

Neural correlates of memory for object identity and object location: effects of aging

Inception, Total Recall, & The Brain: An Introduction to Neuroscience Part 2. Neal G. Simon, Ph.D. Professor Dept. of Biological Sciences

The Impact of Type 2 Diabetes on Cognition

Form D1: Clinician Diagnosis

TGF-ß1 pathway as a new pharmacological target for neuroprotection in AD. Filippo Caraci

Early detection of subjective memory impairment in Parkinson s disease using cerebral perfusion SPECT

correlates with social context behavioral adaptation.

Assessing Cognition. Andreana Haley, Ph.D. Department of Psychology University of Texas at Austin

Alzheimer s Disease Neuroimaging Initiative

Title of file for HTML: Supplementary Information Description: Supplementary Figures, Supplementary Tables and Supplementary References

8/14/2018. The Evolving Concept of Alzheimer s Disease. Epochs of AD Research. Diagnostic schemes have evolved with the research

Brain Structure and Function in Nephropathic Cystinosis

Supplementary Material S3 Further Seed Regions

Confronting the Clinical Challenges of Frontotemporal Dementia

Neuroimaging for Diagnosis of Psychiatric Disorders

On cognitive performance as endpoint in clinical trials Ben Schmand

Transcription:

The Role of Cognitive Reserve in the clinical presentation of Alzheimer s Disease Dorene M. Rentz, PsyD Division of Cognitive and Behavioral Neurology, Brigham and Women s Hospital Co-Director of the Center for Alzheimer Research and Treatment Department of Neurology, Massachusetts General Hospital Director of Neuropsychology, Massachusetts Alzheimer Disease Research Center Associate Professor of Neurology, Harvard Medical School

Famous People with Alzheimer s Disease Burgess Meredith Winston Churchill Charlton Heston Fanfare for the Common Man Aaron Copland Erik Erikson Ronald Reagan Henry Ford

Reserve Model Reserve is a hypothetical concept that refers to the variability observed between brain pathology and the expression of clinical symptoms. This means that some people tolerate disease burden better than others. Stern Y, Neuropsychologia. 2009:47; 2015-2028

Mechanisms of Reserve Theories of why some people can tolerate disease burden better than others: Genetically larger brains (i.e., some individuals have increased synaptic or neuronal capacity)

Brain Reserve Stern, Y. J Int Neuropsych Soc, 2002; 8, 448-460

Total Blessed Score It would appear that a certain amount of the change estimated by plaque count may be accommodated within the reserve capacity of the cerebrum without causing manifest intellectual impairment (page 807). Total Plaque Count

Global Cognitive Function Score Education differentially impacted cognitive function at different strata of AD pathology (Education strata= 22 years, 18 years and 15 years Neurology; 2003; 60: 1909-1915 22 years 18 years 15 years Summary Measure of AD Pathology

Neurology 2006; 66: 1837-1844 AD pathology is found in the brains of older persons without dementia and is related to subtle changes in episodic memory. Weakest association with perceptual speed.

Red and yellow represent Significantly thinner cortex In elderly controls compared SuperAgers SuperAgers perform similar to middle-aged controls on a memory test

Mechanisms of Reserve Lifetime exposures or life course factors creating more efficient brains (i.e., some individuals are able to more easily engage alternate brain networks or utilize different cognitive strategies to solve a problem) Educational advantage Reading ability Occupational and other lifetime activities

Cognitive Reserve Reserve mediates the difference between pathology and performance Stern, 2009, Neuropsychologia; 47: 2015-2028

Aging Gracefully: Compensatory Brain Activity In High Performing Older Adults Roberto Cabeza, et al, NeuroImage 2002, 17:1394-1402 Old-High Adults were matched on a composite memory score with Young Adults. PFC activity during source memory was right lateralized in Young and Old-Low participants but bilateral in Old-High participants. Old-Low recruited similar network as Young, but used it inefficiently. N=12 N=8 N=8

Neurology; 1992; 32: 371-375 After matching subjects for age and disease severity; subjects with higher education had greater hypometabolism indicating that AD was more advanced in this group

Neurology; 1995; 45: 55-60 After controlling for age, education and dementia severity, greater hypoperfusion in parietal regions for subjects whose occupations were associated with higher interpersonal skills and fewer physical demands.

80 70 60 50 40 30 20 10 0 NC IQ-MI IQ-Adjusted Cut-off Standard Cut-off CDR 0

Clinically Significant Longitudinal Decline in IQ-Memory Impaired Rentz, et al, Neuropsychology, 2004; 18: 38-49

SPECT Perfusion Deficits in IQ-adjusted Memory Impairment Rentz et al, JINS; 2007; 13: 821-831 Perfusion decreases in IQ-MI compared to IQ-MN in parietal/precuneus, temporal and opercular frontal are shown in posterior (A), right lateral (B), and superior (C) surface projections. Perfusion increase in IQ-MI compared to IQ-MN is shown in the left medial frontal and rostral anterior cingulate regions (D).

PiB-PET Amyloid Imaging Sperling R, Johnson K NeuroMolecular Medicine 2010

Archives of Neurology; 2008; 65: 1467-1471 Education modifies relation of performance on the Short Blessed Test and amyloid deposition

Annals of Neurology; 2010; 67; 353-364

Normals: Cognitive Performance was related to Cognitive Reserve but not Amyloid Deposition except when a Challenging Memory Test was used DM Rentz, et al. Ann Neurol 2010; 67:353-364.

Figure 1 Figure 2 = -2.21, p= 0.02 2 = 11.13, = -1.32, p= 0.04

β p SCC-Total 0.188 0.025 GDS -0.383 0.70

Summary Cognitive Reserve is a theoretical concept to explain the observation that individuals can remain clinically normal in the context of increasing brain pathology. Cognitive reserve can influence diagnostic tests: Cognition- subjects continue to perform normally Subjects may be apt to have complaints PET imaging reveals greater hypometabolism and increased amyloid deposition MRI structural changes shows increased atrophy Rate of decline is faster once a threshold has been crossed

Implications Individuals with higher cognitive reserve are apt to be misdiagnosed as normal and are at increased risk for not receiving treatments when available While function is maintained longer, the rate of decline is rather steep once the threshold is crossed suggesting that they require further follow-up during the course of the disease Subjective complaints may be a warning that early changes are occurring rather than implying the worried well. Alzheimer Prevention trials will need to take into account the modifying effects of cognitive reserve when selecting subjects for enrollment

Acknowledgements Investigators/ Faculty Reisa A. Sperling, MD Keith A. Johnson, MD Rebecca Amariglio, PhD Kathryn Papp, PhD Yakeel Quiroz-Gaviria, PhD Gad Marshall, MD Jasmeer Chhatwal, MD PhD Aaron Schultz, PhD John Alex Becker, PhD Brendon Boot, MD Tamy-Fee Menendez, BA Seihley Jaimes, BA Alison Pietras, BA Martha Vander Vliet RN Margaret Chute, BA Funding: NIH and Alzheimer s Association ALL THE SUBJECTS WHO MAKE OUR RESEARCH POSSIBLE Research Assistants

THANK YOU!